This adaptive process involves epigenetic reprogramming and transcriptomic remodeling, often driven by loss-of-function alterations in key tumor suppressors such as PTEN, RB1, and TP53, which decouple tumor growth from AR dependency (1–3). This evidence concerns the gene TP53 and neoplasm.